Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.

Alnylam Pharmaceuticals Inc. won a major FDA approval on Thursday, one that could propel the Cambridge company toward a major milestone — finally reaching profitability.

Doctors should prescribe triptans for migraine patients who aren't receiving relief from over-the-counter (OTC) pain ...

Amvuttra’s clearance in a rare form of cardiomyopathy could help Alnylam turn a regular profit — if it can wrest control of a competitive and fast-changing market.